[MYGN] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -105.34%
YoY- -100.86%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 215,400 216,600 216,800 202,300 200,900 193,500 194,000 7.24%
PBT -7,700 3,300 3,600 800 16,100 16,500 3,700 -
Tax -3,400 -3,600 1,000 1,600 3,000 5,200 -28,400 -75.80%
NP -4,200 6,900 2,600 -700 13,100 11,400 32,100 -
Tax Rate - 109.09% -27.78% -200.00% -18.63% -31.52% 767.57% -
Total Cost 219,600 209,700 214,200 203,000 187,800 182,100 161,900 22.60%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -1.95 3.19 1.20 -0.35 6.52 5.89 16.55 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.06 0.09 0.04 -0.01 0.19 0.16 0.46 -
EPS Diluted -0.06 0.09 0.03 -0.01 0.18 0.16 0.45 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.